MIAS Pharma

Executive Summary

MIAS Pharma is a Dublin-based service provider enabling pharmaceutical and biopharma companies to access and commercialize products in the EU and UK markets. Founded in 2015, the company offers a comprehensive suite of regulatory and quality services, including Qualified Person (QP) batch release, Marketing Authorisation Holder (MAH) services, and GMP/GDP compliance support. As a critical partner for international firms navigating complex European regulatory pathways, MIAS Pharma addresses the growing need for specialized expertise in post-Brexit and evolving EU regulatory landscapes. The company's services are essential for companies seeking to maintain or expand their presence in the region without establishing local infrastructure.

Upcoming Catalysts (preview)

• Q4 2026EU Pharmaceutical Legislation Revision Impact80% success
• Q2 2026Expansion into Central and Eastern European Markets60% success
• Q3 2026Partnership with a Top 20 Global Pharma Company50% success